John Reed (Credit: Jeff Rumans)

Sanofi slash­es an­oth­er pro­gram for key mol­e­cule, while keep­ing hopes in hand­ful of rare dis­eases

Sev­er­al years ago, when Sanofi un­veiled a mol­e­cule to pre­vent the ac­cu­mu­la­tion of a cer­tain type of fat in cells, they fig­ured it would work …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.